Coherus Biosciences | CHRS - Capital Social Ordinario

Precio De Mercado
1.52
Cambio Diario
-0.09 -5.59%
Mensual
-6.17%
Anual
47.57%
Q1 Expectativa
1.47




Capital Social Ordinario Cambio Fecha
AbbVie USD 1.77B 1.75B 2025-06
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Akebia Therapeutics USD 265.42M 199K 2025-12
ALKERMES USD 165.61M 503K 2025-12
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Amarin USD 20.81M 13K 2025-12
Amgen USD 539M 1000K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Coherus Biosciences USD 121.16M 4.92M 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Fujifilm JPY 1.21B 19K 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
Merck USD 2.49B 15.79M 2025-09
Myriad Genetics USD 93.5M 400K 2025-12
Pacira USD 41.12M 1.85M 2025-12
Perrigo USD 137.6M 0 2025-12
Pfizer USD 5.69B 1000K 2025-09
PTC Therapeutics USD 81.47M 1.54M 2025-12
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Sarepta Therapeutics USD 104.96M 196K 2025-12
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Vertex Pharmaceuticals USD 254M 0 2025-12
Xencor USD 71.87M 529K 2025-12
Zoetis USD 424.93M 16.54M 2025-12